Pharmacogenetic testing to guide therapeutic decision‐making and improve outcomes for children undergoing anthracycline‐based chemotherapy-Reference-Cited by-同舟云学术

Pharmacogenetic testing to guide therapeutic decision‐making and improve outcomes for children undergoing anthracycline‐based chemotherapy

Published:2021-05-11 Issue:S1 Volume:130 Page:95-99
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharma Tox

Author:

Loucks Catrina M.¹²,Yan Kevin¹²,Tanoshima Reo³⁴,Ross Colin J. D.²⁵,Rassekh Shahrad R.²⁶,Carleton Bruce C.¹²⁷^ORCID

Affiliation:

1. Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine University of British Columbia Vancouver BC Canada

2. BC Children's Hospital Research Institute Vancouver BC Canada

3. Department of Pediatrics Yokohama City University Hospital Yokohama Japan

4. YCU Center for Novel and Exploratory Clinical Trials Yokohama City University Hospital Yokohama Japan

5. Faculty of Pharmaceutical Sciences University of British Columbia Vancouver BC Canada

6. Division of Hematology, Oncology & Bone Marrow Transplant, Department of Pediatrics, Faculty of Medicine University of British Columbia Vancouver BC Canada

7. Pharmaceutical Outcomes Programme BC Children's Hospital Vancouver BC Canada

Funder

Canada's Michael Smith Genome Sciences Centre

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13593

Reference27 articles.

1. Incidence of Adverse Drug Reactions in Hospitalized Patients

2. Understanding genetic variation - the value of systems biology

3. Clinical and economic burden of adverse drug reactions

4. SlawomirskiL AuraaenA KlazingaNS.The economics of patient safety;2017.

5. Adverse drug reactions in children leading to hospital admission;Mitchell AA;Pediatrics,1988

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children;Pharmaceutics;2023-11-30

2. Association between genetic variants of transmembrane transporters and susceptibility to anthracycline‐induced cardiotoxicity: Current understanding and existing evidence;Clinical Genetics;2023-11-14

3. Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients;British Journal of Clinical Pharmacology;2023-01-27

4. Drug-Induced Cardiotoxicity in Children During the Past 30 Years: A Bibliometric Study and Visualization Analysis;Medical Science Monitor;2023-01-13

5. Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series;Journal of Oncology Pharmacy Practice;2022-12-04